Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Dkk3em1flox/Cya
Common Name:
Dkk3-flox
Product ID:
S-CKO-11394
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Dkk3-flox
Strain ID
CKOCMP-50781-Dkk3-B6N-VA
Gene Name
Dkk3
Product ID
S-CKO-11394
Gene Alias
dkk-3; mDkk-3
Background
C57BL/6NCya
NCBI ID
50781
Modification
Conditional knockout
Chromosome
7
Phenotype
MGI:1354952
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Dkk3em1flox/Cya mice (Catalog S-CKO-11394) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000033036
NCBI RefSeq
NM_015814
Target Region
Exon 5~6
Size of Effective Region
~1.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Dkk3, belonging to the DKK family, codes for an evolutionally conserved secreted glycoprotein. It functions as an antagonist of the oncogenic Wnt signaling pathway and has been implicated in multiple biological processes and diseases [3,6,7]. Genetic models like KO/CKO mouse models are valuable for studying its functions.

In muscle-related studies, myofiber-specific ablation of Baf60c in mice led to a robust upregulation of Dkk3, which inhibited muscle stem cell differentiation and attenuated muscle regeneration in vivo. Conversely, Dkk3 blockade promoted muscle regeneration and contraction, indicating Dkk3's role in muscle regeneration through paracrine signaling [1].

In renal fibrosis, knockdown of Dkk3 in UUO mice inhibited oxidative stress, maintained mitochondrial homeostasis, and alleviated kidney damage and fibrosis. Mechanistically, Dkk3 activated the Wnt/β -catenin pathway to increase MFF transcriptional expression, leading to mitochondrial dysfunction [2].

In head and neck squamous cell carcinoma (HNSCC), Dkk3 knockdown significantly decreased cell proliferation, migration, and invasion through decreased AKT phosphorylation, suggesting its oncogenic function in HNSCC [3].

In neuropathic pain, exogenous intrathecal administration of rDKK3 inhibited microglial activation-related signaling, promoted microglia transformation from M1 to M2 type, and decreased pro-inflammatory cytokines, ameliorating neuropathic pain [4].

In chronic obstructive pulmonary disease (COPD)-related sarcopenia, Dkk3 was overexpressed, and its inhibition prevented cigarette-smoking-induced skeletal muscle dysfunction, suggesting it as a potential diagnostic and therapeutic target [5].

In children with chronic kidney disease, urinary DKK3 above the median was associated with a greater 6-month eGFR decline, and it could help identify those who benefit from pharmacological nephroprotection [8].

In conclusion, Dkk3 plays diverse roles in multiple biological processes and disease conditions. Mouse models with Dkk3 knockout or knockdown have revealed its functions in muscle regeneration, renal fibrosis, cancer, neuropathic pain, sarcopenia in COPD, and kidney function decline in children. These findings contribute to understanding disease mechanisms and potentially developing new therapeutic strategies.

References:
1. Xu, Jingya, Li, Xiaofei, Chen, Wei, Shan, Pengfei, Meng, Zhuo-Xian. 2023. Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20221123. https://pubmed.ncbi.nlm.nih.gov/37284884/
2. Song, Jianling, Chen, Yanxia, Chen, Yan, Ke, Ben, Fang, Xiangdong. 2024. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner. In Renal failure, 46, 2343817. doi:10.1080/0886022X.2024.2343817. https://pubmed.ncbi.nlm.nih.gov/38682264/
3. Katase, Naoki, Nagano, Kenichi, Fujita, Shuichi. 2020. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers. In Journal of oral biosciences, 62, 9-15. doi:10.1016/j.job.2020.01.008. https://pubmed.ncbi.nlm.nih.gov/32032750/
4. Zhang, Long-Qing, Gao, Shao-Jie, Sun, Jia, Zhou, Ya-Qun, Mei, Wei. 2022. DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. In Journal of neuroinflammation, 19, 129. doi:10.1186/s12974-022-02495-x. https://pubmed.ncbi.nlm.nih.gov/35658977/
5. Wang, Zilin, Deng, Mingming, Xu, Weidong, Zhou, Xiaoming, Hou, Gang. 2024. DKK3 as a diagnostic marker and potential therapeutic target for sarcopenia in chronic obstructive pulmonary disease. In Redox biology, 78, 103434. doi:10.1016/j.redox.2024.103434. https://pubmed.ncbi.nlm.nih.gov/39571512/
6. Hamzehzadeh, Leila, Caraglia, Michele, Atkin, Stephen L, Sahebkar, Amirhossein. 2018. Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers? In Journal of cellular physiology, 233, 4595-4605. doi:10.1002/jcp.26313. https://pubmed.ncbi.nlm.nih.gov/29206297/
7. Xia, Zhiliang, Du, Dan, Zhang, Zhi, Guo, Xiong, He, Ziqiu. 2024. WIF1 and DKK3 in prostate cancer: from molecular pathways to therapeutic targets: a narrative review. In Translational andrology and urology, 13, 2601-2616. doi:10.21037/tau-24-304. https://pubmed.ncbi.nlm.nih.gov/39698576/
8. Speer, Thimoteus, Schunk, Stefan J, Sarakpi, Tamim, Fliser, Danilo, Schaefer, Franz. 2023. Urinary DKK3 as a biomarker for short-term kidney function decline in children with chronic kidney disease: an observational cohort study. In The Lancet. Child & adolescent health, 7, 405-414. doi:10.1016/S2352-4642(23)00049-4. https://pubmed.ncbi.nlm.nih.gov/37119829/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest